ArticleCrohn's & colitis 3602021

Adalimumab, Infliximab, and Vedolizumab in Treatment of Ulcerative Colitis: A Long-Term Retrospective Study in a Tertiary Referral Center.

Ann-Lorie Gagnon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.